Forest Labs and Furiex Pharmaceuticals on Monday announced that Forest will acquire Furiex for $95 per share, or approximately $1.1 billion in cash.
Mylan is challenging the patent protection on a drug used to treat fibromyalgia, prompting a lawsuit from the branded drug's manufacturers.
Royalty Pharma has hired Marshall Urist as VP research and investments, the company said Friday.
Royalty Pharma will not buy Irish drug maker Elan Corp., the company said Tuesday.
Irish drug maker Elan Corp. said Friday it was looking to sell itself off to a New York-based company that invests in drug royalties after rejecting a previous offer.
A privately owned drug maker in New York is offering $6.5 billion for Irish drug maker Elan Corp., but hasn't heard back from it, according to published reports.